CTC Alternative Strategies, Ltd.
Source: SEC Form 13F · as of Mar 2026CTC Alternative Strategies, Ltd. holds 14 biotech & pharma companies tracked by BioSniper, totaling $656K in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$656K
| Company | Shares | Value |
|---|---|---|
| PRAXPraxis Precision Medicines, Inc. | 925 | $298K |
| MNKDMANNKIND CORP | 16,400 | $40K |
| OCGNOcugen, Inc. | 18,633 | $34K |
| PALIPALISADE BIO, INC. | 17,441 | $31K |
| ZNTLZentalis Pharmaceuticals, Inc. | 12,500 | $29K |
| CRBUCaribou Biosciences, Inc. | 15,076 | $29K |
| CCCCC4 Therapeutics, Inc. | 10,792 | $28K |
| MBOTMicrobot Medical Inc. | 11,718 | $28K |
| LXRXLEXICON PHARMACEUTICALS, INC. | 17,544 | $27K |
| LCTXLineage Cell Therapeutics, Inc. | 15,307 | $24K |
| PROKPROKIDNEY CORP. | 13,453 | $24K |
| ALTSALT5 Sigma Corp | 21,126 | $23K |
| IVVDInvivyd, Inc. | 17,648 | $23K |
| RANIRani Therapeutics Holdings, Inc. | 23,622 | $17K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.